AEGiS-UPI: (UPI Science News) Dueling over medical marijuana issues United Press InternationalImportant note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.
Click here to return to United Press International main menu
DonateNow
Print this article




(UPI Science News) Dueling over medical marijuana issues

United Press International; Wednesday, October 1, 1997 - 1:35 PM EDT


WASHINGTON, Oct. 1 (UPI) _ Foes anad fans are dueling over the medical virtues of marijuana before a congressional subcommittee as more states consider propositions to legalize medical uses of cannibis.

Bill McCollum, chairman of the House Judiciary subcommittee on crime opened the hearing today saying, "I find the medical marijuana movement very troubling." McCollum said, its supporters "exploit the suffering of the terminally ill to advance their drug legalization agenda."

The committee convened the hearing as a growing number of states are considering propositions to legalize marijuana medical uses. In 1996, Californa and Arizona passed ballot initiatives permitting physicians to prescribe marijuana.

National drug czar Gen. Barry McCaffrey, said, he that such initiatives are "subverting the public health process, and declaring smoked marijuana a 'medicine' threatens the integrity of our established medical safeguards."

In his written testimony, Dr. Lester Grinspoon from Harvard Medical School said the medical uses of marijuana have been recognized for thousands for years.

Grinspoon said, "It is far safer than most medicines prescribed by doctors daily and often works for patients who cannot tolerate the side effects of other drugs."

He referred to clinical experience that marijuana helps patients with such ailments as AIDS weightloss syndrome, and severe nausea and vomitting.

But McCaffrey said, "If sound medical research demonstrates there are medical uses for smoked marijuana, there are appropriate and responsible procedures for rescheduling this mind-influencing drug."


971001
UP971001


Copyright © 1997 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .